Happy news! Marick's disease vaccine (CVTR strain) obtained the national new veterinary drug certificate

On September 27,2021, the Ministry of Agriculture and Rural Affairs of the People's Republic of China issued notice No.473, according to the "Regulations on the Administration of Veterinary Drugs" and "Veterinary Drug Registration Measures", Dahuanong received the new horse lion's disease vaccine (CVTR strain) veterinary drug registration certificate, certificate number: (2021) new veterinary drug certificate No.61.

 Marek's disease is caused by the Marek's disease virus in the α subgroup of herpesviridae, which endangers the lymphatic system and nervous system and causes tumors of peripheral nerves, gonads, iris, various internal organs, muscles and skin. At present, the disease is mainly based on vaccine prevention and control. The live chicken Malik's disease vaccine (CVTR strain) independently developed by Dahuanong Company has the characteristics of good safety and fast immune formation period. The immune challenge protection test shows that the protection rate of the vaccine against the super toxic virus is more than 90%.

With the mission of "being an animal health expert, serving human health", Dahuanong has been committed to the development, production and promotion of ecological, green and environmentally friendly animal health products. The company has successfully produced and sold live Malick's disease vaccine (814 strains) for more than ten years, and has accumulated rich experience in research and development, production and sales. Live Malick's disease vaccine (CVTR strain) will help the majority of breeding enterprises to better prevent and control Malick's disease, and provide consumers with more green and healthy food.

Luo Qiong, Huang Jiebin